Package 69238-1993-1

Brand: butalbital, aspirin, caffeine and codeine phosphate

Generic: butalbital, aspirin, caffeine and codeine phosphate
NDC Package

Package Facts

Identity

Package NDC 69238-1993-1
Digits Only 6923819931
Product NDC 69238-1993
Description

100 CAPSULE in 1 BOTTLE (69238-1993-1)

Marketing

Marketing Status
Marketed Since 2019-04-01
Brand butalbital, aspirin, caffeine and codeine phosphate
Generic butalbital, aspirin, caffeine and codeine phosphate
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "f3869a7a-b5f3-4279-b07b-ff01a8c2a286", "openfda": {"nui": ["N0000000160", "N0000008836", "M0001335", "N0000175722", "N0000175578", "N0000008832", "N0000175693", "M0002177", "N0000175739", "N0000175729", "N0000175790", "M0023046"], "upc": ["0369238199314"], "unii": ["R16CO5Y76E", "KHS0AZ4JVK", "3G6A5W338E", "GSL05Y1MN6"], "rxcui": ["994237"], "spl_set_id": ["828e30fa-7bb1-486b-80ee-806fce45e4e4"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]", "Barbiturates [CS]", "Xanthines [CS]"], "pharm_class_pe": ["Decreased Prostaglandin Production [PE]", "Decreased Platelet Aggregation [PE]", "Central Nervous System Stimulation [PE]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]", "Barbiturate [EPC]", "Central Nervous System Stimulant [EPC]", "Methylxanthine [EPC]"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["Amneal Pharmaceuticals of New York, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE in 1 BOTTLE (69238-1993-1)", "package_ndc": "69238-1993-1", "marketing_start_date": "20190401"}], "brand_name": "BUTALBITAL, ASPIRIN, CAFFEINE and CODEINE PHOSPHATE", "product_id": "69238-1993_f3869a7a-b5f3-4279-b07b-ff01a8c2a286", "dosage_form": "CAPSULE", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Barbiturate [EPC]", "Barbiturates [CS]", "Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulation [PE]", "Cyclooxygenase Inhibitors [MoA]", "Decreased Platelet Aggregation [PE]", "Decreased Prostaglandin Production [PE]", "Full Opioid Agonists [MoA]", "Methylxanthine [EPC]", "Nonsteroidal Anti-inflammatory Drug [EPC]", "Opioid Agonist [EPC]", "Platelet Aggregation Inhibitor [EPC]", "Xanthines [CS]"], "product_ndc": "69238-1993", "dea_schedule": "CIII", "generic_name": "BUTALBITAL, ASPIRIN, CAFFEINE and CODEINE PHOSPHATE", "labeler_name": "Amneal Pharmaceuticals of New York, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "BUTALBITAL, ASPIRIN, CAFFEINE and CODEINE PHOSPHATE", "active_ingredients": [{"name": "ASPIRIN", "strength": "325 mg/1"}, {"name": "BUTALBITAL", "strength": "50 mg/1"}, {"name": "CAFFEINE", "strength": "40 mg/1"}, {"name": "CODEINE PHOSPHATE", "strength": "30 mg/1"}], "application_number": "ANDA074951", "marketing_category": "ANDA", "marketing_start_date": "20190401", "listing_expiration_date": "20271231"}